(19)
(11) EP 1 951 277 A2

(12)

(88) Date of publication A3:
14.06.2007

(43) Date of publication:
06.08.2008 Bulletin 2008/32

(21) Application number: 06825957.1

(22) Date of filing: 16.10.2006
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
(86) International application number:
PCT/US2006/040207
(87) International publication number:
WO 2007/047504 (26.04.2007 Gazette 2007/17)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 14.10.2005 US 726198 P

(71) Applicant: Biorexis Pharmaceutical Corporation
New York, NY 10017-5755 (US)

(72) Inventors:
  • SADEGHI, Homayoun
    King Of Prussia, Pennsylvania 19406-2675 (US)
  • TURNER, Andrew, J.
    King Of Prussia, Pennsylvania 19406-2675 (US)
  • PRIOR, Christopher, P.
    King Of Prussia, Pennsylvania 19406-2675 (US)
  • BALLANCE, David, J.
    King Of Prussia, Pennsylvania 19406-2675 (US)

(74) Representative: England, Peter Michael et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich Kent CT13 9NJ
Sandwich Kent CT13 9NJ (GB)

   


(54) NATRIURETIC PEPTIDE MODIFIED TRANSFERRIN FUSION PROTEINS